Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

Future Market Insights provides reliable, data-driven insights that empower stakeholders to make informed decisions in the ...

Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...

Two-day-old baby KJ Muldoon only had a few months left to live. Diagnosed with a rare and fatal genetic disease, his life hung in the balance — the only known treatment offering little hope of ...

A major breakthrough in cancer research has shown that using CRISPR gene editing technology to turn off a specific gene can help fight chemotherapy resistance in lung cancer. This discovery could open ...

Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

The U.S. Cellular Reprogramming Tools Market is entering a high-growth decade, projected to expand from USD 446.8 million in ...

Sugar beet (Beta vulgaris L.) plays an important role in global sugar production, comprising almost 20% of the output. With climate change intensifying, ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...